Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization.

Lipids in health and disease - 22 Jun 2024

Hu Xiao, Zhang Peng, Gao Yuan, Ding Wen-Wen, Cheng Xue-Er, Shi Qian-Qian, Li Sheng, Zhu Yan-Yu, Pan Hai-Feng, Wang Peng

Abstract excerpt

BACKGROUNDS: A growing body of evidence has highlighted the interactions of lipids metabolism and immune regulation. Nevertheless, there is still a lack of evidence regarding the causality between lipids and autoimmune diseases (ADs), as well as their possibility as drug targets for ADs. OBJECTIVES: This study was conducted to comprehensively understand the casual associations between lipid traits and ADs, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Diseases
Share to Hydroxymethylglutaryl CoA Reductases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypolipidemic Agents

Share to Lipid Metabolism

Share to Lipids

Share to Mendelian Randomization Analysis

Share to Polymorphism, Single Nucleotide

Share to Protein Interaction Maps

Source

Open in PubMed Open full text

Identifiers

PMID: 38909219
DOI: 10.1186/s12944-024-02181-2
PMCID: PMC11193261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization.PMID 38909219Read ↗

Potential association of genetically predicted lipid and lipid-modifying drugs with rheumatoid arthritis: A Mendelian randomization study.Semantic proximity Read ↗

Novel insights into causal effects of lipid and lipid-lowering targets with autoimmune thyroid disease: A Mendelian randomization studySemantic proximity Read ↗

Systematic druggable genome-wide Mendelian randomization identifies novel therapeutic targets or repurposing opportunities for rheumatoid arthritisSemantic proximity Read ↗

Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study.Semantic proximity Read ↗

Mendelian randomization for autoimmune diseases: exploring causal links and drug targets in plasma proteomeSemantic proximity Read ↗

Integrative mendelian randomization approaches for therapeutic target prioritisation in immune-mediated diseases.Semantic proximity Read ↗

Association of lipid-lowering drugs with osteoarthritis outcomes from a drug-target Mendelian randomization study.Semantic proximity Read ↗

Integrative Mendelian Randomization approaches for therapeutic target prioritisation in immune-mediated diseasesSemantic proximity Read ↗

Genetic Association of Lipid-Lowering Drug Target Genes with Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study.Semantic proximity Read ↗

Integrative Analysis of Genetic, Proteomic, and Transcriptomic Data Reveals Novel Therapeutic Targets for Rheumatoid ArthritisSemantic proximity Read ↗

Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.Semantic proximity Read ↗

Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.